Sandy Napel, PhD
Professor of Radiology
Co-chief, Integrative Biomedical Imaging Informatics at Stanford (IBIIS)
Co-chief, Stanford Radiology 3D and Quantitative (3DQ)
Drs. Napel and Daniel will initially appoint the Steering Committee (SC), which consists of themselves and 4 Program Faculty, who will serve for two years.
We have assembled an outstanding Advisory Committee, which meets annually, consisting of both Stanford faculty and external advisors.
Heike Daldrup-Link, MD
Professor of Radiology and, by courtesy, Pediatrics (Hematology/Oncology)
Director, Pediatric Molecular Imaging, Molecular Imaging Program at Stanford
Co-Director, Cancer Imaging & Early Detection Program, Stanford Cancer Institute
Dr. Daldrup-Link is a leading expert in pediatric cancer imaging. In addition, she is Director of the Stanford Radiology Diversity Initiative, and will help steer the program to be attractive to, and respectful and accomodating of faculty, staff, and trainees from diverse cultural, ethnic, gender, and abilities populations.
Gary Glover, PhD
Professor of Radiology, Neurosciences & Biophysics
Professor of Electrical Engineering and Psychology (by courtesy)
Director, Radiological Sciences Laboratory
Dr. Glover is a leading expert in MR imaging and its applications. In addition, he brings almost 20 years of experience in this T32 training program, and management experience from directing the Radiological Sciences Laboratory and a large NCRR Research Resource funded via the P41 mechanism, the Center for Advanced Magnetic Resonance Technology (CAMRT) at Stanford.
Susan Knox, MD
Associate Professor of Radiation Oncology - Radiation Therapy
Dr. Knox specializes in cancer therapy, with her work focusing on radioimmunotherapy, targeted therapies, novel radiosensitizers and radioprotectors, and more recently, the use of radiation therapy as a component of tumor vaccine strategies. She has been on the Advisory Committee for 11 years. She has been of great service to our program, providing a vital link to the needs on the therapy side of cancer imaging. Dr. Knox also has over 25 years of experience leading clinical trials, including a number of investigator initiated trials, some of which were based on translational research in her laboratory. In addition, she is currently the faculty director of the PRMS and Chair of the DSMC for the Stanford Cancer Institute. Through her experience as PI and mentor for clinical trials she will be able to advise, in particular, in areas of translational research.
Norbert Pelc, ScD
Professor of Radiology and Bioengineering
Chair of Bioengineering
He has been active in diagnostic imaging research for more than 35 years, having made major contributions to CT, MR, ultrasound, x-ray, and nuclear medicine imaging. He has almost 20 years of experience in this T32 training program, and has mentored many pre- and postdoctoral fellows, many of whom have gone on to successful careers in academia and industry. In addition, he leads a T32 (Training In Biomedical Imaging Instrumentation - TBI2) that focuses on pre-doctoral training.
Yvonne (Bonnie) Maldonado, MD
Professor of Pediatrics (Infectious Diseases) and of Health Research and Policy
Senior Associate Dean for Faculty Development and Diversity in the School of Medicine
Michael McNitt-Gray, PhD
Professor of Radiology, David Geffen School Medicine at UCLA
Dr. McNitt-Gray brings his experience as the Program Director of the UCLA Physics and Biology in Medicine Interdepartmental Graduate Program, an interdisciplinary program supported for over 40 years with an NIH T32 training grant. He has also devoted much of his research career to investigations into imaging in the detection, diagnosis and staging of disease, especially cancer. His primary focus has been on X-ray Computed Tomography (CT) with a specific focus on quantitative imaging.
John Gore, PhD
Professor of Molecular Physiology and Biophysics, Radiology and Radiological Sciences, Biomedical Engineering and Physics and Astronomy, Vanderbilt University Institute of Imaging Science
Dr. Gore brings experience directing both R25T and T32 NCI supported Training Programs, and has been active in the development of imaging methods for over 40 years, more recently focusing on the development of imaging biomarkers in cancer.